FDA Releases Guidance on Cyclosporine and Tacrolimus Assays for Transplant Patients

Summary

The FDA has released a guidance document for the Class II special controls of cyclosporine and tacrolimus assays, which aid in transplant patient management. The FDA is also issuing a final rule to reclassify these assays into Class II, as announced elsewhere in the Federal Register.